Table 2

Cytochrome P450 isozymes: substrates and inducing agents determined from human and rodent studies

Cytochrome P450C/I2-a Inducing Agent (If Any)Substrates Used in This Study2-b
1A1I3MCBenzo(a)pyrene Phenacetin
1A2C, I3MC, β-naphthoflavone7-Ethoxyresorufin 7-Ethoxycoumarin2-c Phenacetin
2A6C??Coumarin
2B1C, IPhenobarbital7-Methoxycoumarin 7-Pentoxyresorufin Aminopyrine 7-Benzyloxyresorufin
2B2IPhenobarbital7-Methoxycoumarin 7-Pentoxyresorufin Aminopyrine 7-Benzyloxyresorufin
2B6C??7-Ethoxy-4-methylcoumarin 7-Benzyloxyresorufin
2C6, 2C11, 2C13C, IPhenobarbitalDiclofenac Tolbutamide Mephenytoin
2D6C??Propranolol Bufuralol Dextromethorphan
2E1C,IAcetone, ethanolAniline2-d p-Nitrophenol2-d Chlorzoxazone
3A1/3A2C, IDexamethasone PhenobarbitalCortisol Erythromycin Dextromethorphan Androstenedione Testosterone
4A1/3C, IClofibrateLauric acid
  • 3MC, 3-methylcholanthrene.

  • 2-a  Constitutively (C) expressed or induced (I) expression. The concentration of a constitutively expressed P450 can be augmented by inducing agents. The expression/presence of the “induced” P450 enzymes is observed only following in vivo exposure to inducing agents.

  • 2-b  The substrate specificity/selectivity for a given P450 is based on rodent and human studies (Omiecinski et al., 1999 and Wrighton and Stevens, 1992).

  • 2-c  May also be metabolized by 2B1/2 and 2E1.

  • 2-d  May also be metabolized by 2A1.